Detalhe da pesquisa
1.
A programme for early diagnosis of atrial fibrillation: a multi-centre study in primary care.
Fam Pract
; 39(1): 99-105, 2022 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34160603
2.
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
Eur J Haematol
; 105(5): 597-607, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710500
3.
IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection.
Ann Hematol
; 99(12): 2953-2956, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583087
4.
Impact of IPSS-M implementation in real-life clinical practice.
Front Oncol
; 13: 1199023, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37274292
5.
Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.
Cancers (Basel)
; 15(16)2023 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627050
6.
Serious Game for the Screening of Central Auditory Processing Disorder in School-Age Children: Development and Validation Study.
JMIR Serious Games
; 11: e40284, 2023 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099359
7.
The Potential of Digital Screening Tools for Childhood ADHD in School Environments: A Preliminary Study.
Healthcare (Basel)
; 11(20)2023 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37893869
8.
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT.
Leukemia
; 37(3): 659-669, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36596983
9.
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1188818, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37342332
10.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1243241, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37662957
11.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1349296, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268917
12.
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia.
Ther Adv Hematol
; 12: 20406207211039326, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34471509
13.
Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.
J Hematol Oncol
; 14(1): 126, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404440
14.
New therapies for relapsed or refractory aggressive B-cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group.
Hemasphere
; 8(4): e70, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650598
15.
Clonal hematopoiesis-defining mutations have no impact on the development of thrombosis in a cohort of patients with myeloid pathology.
Leuk Res
; 108: 106613, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34087683